Ockham

Ockham acquires Nexus Oncology, expanding clinically and geographically

Monday, February 13, 2012 05:58 AM

Two small but powerful oncology-focused CROs are now one. Ockham Development Group of Cary, N.C., has acquired Nexus Oncology of Edinburgh, Scotland. 

More... »


Ockham names Smith senior director

Wednesday, August 10, 2011 12:03 PM

Meghann Smith has joined Ockham as senior director, global therapeutic strategic development within the OckhamCROTM division. Smith will provide Ockham clients and functional teams with senior-level strategic guidance, risk mitigation analysis and solutions throughout the life-cycle of projects to help ensure study and program optimization on the regional, global and project/program levels with a primary therapeutic focus in hematology and oncology.

More... »



CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs